Description

Adoptive transfer of T cells engineered to express synthetic antigen-specific T cell receptors (TCRs) has provocative therapeutic applications for treating cancer. However, expressing these synthetic TCRs in a CD4+ T cell line is a challenge.

Downloads
pdf (2.5 MB)

Download count: 0

Details

Contributors
Date Created
2020
Resource Type
  • Text
  • Collections this item is in
    Note
    • Masters Thesis Biology 2020

    Machine-readable links